Century Therapeutics Inc (NASDAQ:IPSC) currently has a daily average trading volume of 862.65K but it saw 2267352 shares traded in last market. With a market cap of 53.90M USD, the company’s current market price of $0.63 came rising about 11.24 while comparing to the previous closing price of $0.56. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.29 and as low as $0.34. In the recent trading on the day, stock has struck highest price mark of $0.56 while lowest mark touched by it was $0.642.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Rodman & Renshaw which initiated the stock as “Buy” in its note to investors issued on August 08, 2024, recommending a price target of $6 for it. JP Morgan downgraded its recommendation for the stock as a “Neutral” from “Overweight” on August 28, 2023 while assigning a price target range of $28-$5. Chardan Capital Markets also issued its recommendations for the stock as it initiated the price target for the stock is $19.
Over the week, IPSC’s stock price is moving 15.23% up while it is 1.53% when we observe its performance for the past one month. Year-to-date it is -72.07% down and over the past year, the stock is showing a downside performance of -38.05%.
The company is expected to be releasing its next quarterly report on 2025-May-15, for which analysts forecasted an EPS of -0.38 while estimate for next year EPS is -0.31.
Currently, Century Therapeutics Inc’s total number of outstanding shares is 86.15M with 24.75% of that held by the insiders while 50.11% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -7.61% and return on equity (ROE) at -10.49%. Stock’s beta reads 1.78. Stock has a price to book (P/B) ratio of 0.22 while price to sale or P/S ratio amounts to 0.47. Its return on asset (ROA) is -6.61% on average.
